Greg Blair

Greg is a dynamic life sciences leader with experience across business development, commercial, product development, and finance roles. He is responsible for building and executing an external innovation strategy to maximize shareholder value.

Greg joined Zomedica from Elanco Animal Health, where he was known for his collaborative approach to creating strategic alliances that built trust and confidence with partners across the industry. While at Elanco, Greg delivered multiple successful transactions, including acquisitions, divestitures, strategic alliances, equity investments, and licensing transactions.

He has dedicated his career to leading teams that deliver innovative solutions for customers with companies such as Johnson and Johnson, Intuitive Surgical and Enteromedics. Greg’s passion for innovation and pursuit of technologies that solve unmet needs, improve clinicians’ practices and enrich patient lives led him to launch numerous innovative products throughout his career.